Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Denali Therapeutics Inc. (DNLI), most recent 12 months reported: revenue $0, net loss $511.45M, free cash flow -$422.1M. Latest balance sheet on file: liquid cash $710.47M. From SEC filings. More on Denali Therapeutics Inc.: Revenue · Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): Calidi Biotherapeutics, Inc. · COMPASS THERAPEUTICS, INC. · MOSAIC IMMUNOENGINEERING, INC. · CEL-SCI CORPORATION · ELOXX PHARMACEUTICALS, INC. · enGene Therapeutics Inc. · ENTERA BIO LTD. · ESTRELLA IMMUNOPHARMA, INC.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.